| ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
| BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
| BTG3 |
Q14201
|
BTG anti-proliferation factor 3
|
|
0.92 |
0.528 |
0.808 |
| CAV1 |
Q03135
|
caveolin 1
|
Enzyme modulator
|
8.3E-03 |
0.388 |
0.885 |
| CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
| CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CD1A |
P06126
|
CD1a molecule
|
|
4.2E-24 |
0.543 |
0.769 |
| CD27 |
P26842
|
CD27 molecule
|
|
1.0E-02 |
0.517 |
0.692 |
| CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
| CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
| CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
| CD86 |
P42081
|
CD86 molecule
|
|
0.95 |
0.483 |
0.769 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
| CXCL9 |
Q07325
|
C-X-C motif chemokine ligand 9
|
Signaling
|
2.9E-03 |
0.462 |
0.808 |
| DPP4 |
P27487
|
dipeptidyl peptidase 4
|
Enzyme
|
7.3E-09 |
0.420 |
0.808 |
| FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
| FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
| GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |